Correlation between activated clotting time and activated partial thromboplastin times

被引:33
作者
Smythe, MA
Koerber, JM
Nowak, SN
Mattson, JC
Begle, RL
Westley, SJ
Balasubramaniam, M
机构
[1] William Beaumont Hosp, Dept Pharmaceut Serv, Invest Drug Serv, Royal Oak, MI 48073 USA
[2] Wayne State Univ, Dept Pharm Practice, Detroit, MI USA
[3] William Beaumont Hosp, Dept Clin Pathol, Royal Oak, MI 48072 USA
[4] William Beaumont Hosp, Med Intens Care Unit, Dept Pulm & Crit Care Med, Royal Oak, MI 48072 USA
[5] William Beaumont Hosp, Res Inst, Royal Oak, MI 48072 USA
关键词
activated clotting time; activated partial thromboplastin time; heparin;
D O I
10.1345/aph.1A141
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To evaluate the correlation between clotting time tests and heparin concentration, the correlation between activated clotting time (ACT) and activated partial thromboplastin time (aPTT) results, and to compare the clinical decisions based on ACT results with those based on aPTT results. METHODS: Retrospective evaluation of a large database containing heparin concentrations, ACT results (1 device), and aPTT results (3 different instruments: 2 bedside, 1 laboratory-based), Correlations between heparin concentrations and clotting time tests and between ACT results and aPTT results were determined. Clinical decisions regarding heparin dosage adjustments based on ACT results were compared with those based on aPTT results. RESULTS: Correlations between clotting time tests and heparin concentrations were r = 0.72 for ACT and r = 0.74 -0.86 for the aPTT instruments. The laboratory-based aPTT had the highest correlation to heparin concentrations. The correlation between ACT and aPTT results ranged from r = 0.64 - 0.67. Heparin dosage adjustment decisions based on ACT results agreed with decisions based on aPTT results 59 - 63% of the time. CONCLUSIONS: The laboratory-based aPTT has a stronger correlation to heparin concentration than the bedside-based aPTT and ACT. The correlation between ACT and aPTT was similar among 3 different aPTT instruments. Decisions to adjust heparin therapy based on ACT results differed from decisions based on aPTT results more than one-third of the time.
引用
收藏
页码:7 / 11
页数:5
相关论文
共 15 条
[1]   COMPARISON OF BEDSIDE AND HOSPITAL LABORATORY COAGULATION STUDIES DURING AND AFTER CORONARY INTERVENTION [J].
BLUMENTHAL, RS ;
CARTER, AJ ;
RESAR, JR ;
COOMBS, V ;
GLOTH, ST ;
DALAL, J ;
BRINKER, JA .
CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1995, 35 (01) :9-17
[2]   ACTIVATED CLOTTING TIMES AND ACTIVATED PARTIAL THROMBOPLASTIN TIMES IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY WHO RECEIVE BOLUS DOSES OF HEPARIN [J].
DOUGHERTY, KG ;
GAOS, CM ;
BUSH, HS ;
LEACHMAN, DR ;
FERGUSON, JJ .
CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1992, 26 (04) :260-263
[3]   Heparin management test versus activated coagulation time during cardiovascular surgery: Correlation with anti-Xa activity [J].
Fitch, JCK ;
Geary, KLB ;
Mirto, GP ;
Byrne, DW ;
Hines, RL .
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 1999, 13 (01) :53-57
[4]   Heparin and low-molecular-weight heparin - Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety [J].
Hirsh, J ;
Warkentin, TE ;
Shaughnessy, SG ;
Anand, SS ;
Halperin, JL ;
Raschke, R ;
Granger, C ;
Ohman, EM ;
Dalen, JE .
CHEST, 2001, 119 (01) :64S-94S
[5]   Correlation of activated clotting time and activated partial thromboplastin time to plasma heparin concentration [J].
Koerber, JM ;
Smythe, MA ;
Begle, RL ;
Mattson, JC ;
Kershaw, BP ;
Westley, SJ .
PHARMACOTHERAPY, 1999, 19 (08) :922-931
[6]   ON THE VALUE OF THE ACTIVATED CLOTTING TIME FOR MONITORING HEPARIN-THERAPY IN ACUTE CORONARY SYNDROMES [J].
MELANDRI, G ;
BRANZI, A ;
TRAINI, AM ;
SEMPRINI, F ;
CERVI, V ;
MAGNANI, B .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (05) :469-471
[7]  
NATH FC, 1993, CAN J CARDIOL, V9, P797
[8]  
Olson JD, 1998, ARCH PATHOL LAB MED, V122, P782
[9]   A COMPARISON OF 5 DEVICES FOR THE BEDSIDE MONITORING OF HEPARIN-THERAPY [J].
ONEILL, AI ;
MCALLISTER, C ;
CORKE, CF ;
PARKIN, JD .
ANAESTHESIA AND INTENSIVE CARE, 1991, 19 (04) :592-601
[10]   BEDSIDE MONITORING OF HEPARIN-THERAPY - COMPARISON OF ACTIVATED CLOTTING TIME TO ACTIVATED PARTIAL THROMBOPLASTIN TIME [J].
REINER, JS ;
COYNE, KS ;
LUNDERGAN, CF ;
ROSS, AM .
CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1994, 32 (01) :49-52